Guardian Pharmacy Services, Inc.
GRDN
$20.09
$0.763.93%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | 19.66% | 13.53% | 15.58% | 10.91% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 19.66% | 13.53% | 15.58% | 10.91% | |
| Cost of Revenue | 20.41% | 13.00% | 16.08% | 11.93% | |
| Gross Profit | 16.64% | 15.64% | 13.62% | 7.00% | |
| SG&A Expenses | 182.78% | 82.70% | 2.15% | 78.87% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 55.72% | 20.65% | 13.51% | 21.84% | |
| Operating Income | -1,552.65% | -50.71% | 93.11% | -139.42% | |
| Income Before Tax | -1,410.24% | -53.07% | 100.76% | -145.43% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -1,412.75% | -53.07% | 100.76% | -145.43% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -58.86% | -60.38% | -18.87% | -16.03% | |
| Net Income | -897.70% | -68.77% | 293.49% | -196.52% | |
| EBIT | -1,552.65% | -50.71% | 93.11% | -139.42% | |
| EBITDA | -5,787.65% | -41.85% | 58.33% | -108.34% | |
| EPS Basic | -- | -- | -- | -- | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | -- | -- | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | -- | -- | |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | 0.81% | 1.42% | -0.51% | -3.88% | |
